ReviewRSC advances2026
"Biodegradable caterpillar inspired soft robotic systems for targeted therapeutic delivery with intelligent
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Caterpillar-theorized soft robots are being developed as a new device for targeted drug delivery and less-invasive diagnostics. They replicate caterpillar movement through versatile, wave-like peristaltic motion and soft, adaptable structures that enable them to navigate narrow, curved, or irregular pathways in the body that conventional devices often cannot. Advances in fabrication, such as 3D printing and biodegradable magnetic composites, have enabled the development of soft robots that are both flexible and biocompatible and that can safely break down once their task is complete. Actuation methods, such as magnetic or pneumatic control, combined with built-in sensors, enable these robots to deliver drugs to specific sites at precise times while monitoring conditions around them; moreover, beyond delivering medication, they can also be used for imaging and early disease detection, specifically in the gastrointestinal tract and cancer care. There are still challenges to address, including producing the robots at a larger scale, reducing their size without sacrificing functionality, ensuring safety within the body, reliability and meeting regulatory standards. Meeting these challenges will require close cooperation among engineers, materials scientists and clinicians to develop multifunctional platforms that integrate biomimetic movement with precise drug delivery, resulting in safer, effective and personalized treatments.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.